SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.580-3.0%Oct 28 3:59 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dorightbythem who wrote (1204)10/23/2025 5:09:19 PM
From: bobbseytwins20013 Recommendations

Recommended By
Fitzhughlaw
JJINV
urslor

   of 1216
 
Slow ramp up of sales? Sales growth looks fine to us. Like the old IMMU, IBRX needs investment grade news that surprises and pleases investors and makes them more confident to buy down here, not simply "feel good" blurbs that help for an hour. Until that happens, PSS is stuck posting on X, going on podcasts, and frustrating everyone, while he begs the FDA to act responsibly. If there is any justice in the world something positive should happen soon.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News